ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,493.70
0.55%
S&P ASX All Technology
3,942.30
0.62%
Brent Oil
75.525
-0.52%
US Dollar vs AUD
1.60636
0.22%
Bitcoin
105,161.91
1.37%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. ATAI Life Sciences NV (9VC) Share Price

ATAI Life Sciences NV

ATAI Life Sciences NV (9VC)

TG
1.4455
0.00
( 0.00% )
Updated: 23:00:01
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.4455
Bid
1.4295
Offer
1.4865
Volume
0.00
0.00 Day's Range 0.00
0.93 52 Week Range 2.529
Market Cap
242.558M
Previous Close
1.4455
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
21,350
Shares Outstanding
167,802,396
Dividend Yield
-
PE Ratio
-6.26
Earnings Per Share (EPS)
-0.24
Revenue
314k
Net Profit
-40.22M

About ATAI Life Sciences NV

Sector
Intermediate Care Facilities
Industry
Intermediate Care Facilities
Website
www.atai.life
Headquarters
Berlin, Deu
Founded
-
ATAI Life Sciences NV is listed in the Intermediate Care Facilities sector of the Tradegate (DE) with ticker 9VC. The last closing price for ATAI Life Sciences NV was 1.45 €. Over the last year, ATAI Life Sciences NV shares have traded in a share price range of 0.93 € to 2.529 €.

ATAI Life Sciences NV currently has 167,802,396 shares in issue. The market capitalisation of ATAI Life Sciences NV is 242.56 € million. ATAI Life Sciences NV has a price to earnings ratio (PE ratio) of -6.26.

Ask ADVFN Intelligence (AI)

9VC Latest News

More News

atai Life Sciences gibt Finanzergebnisse des zweiten Quartals 2023 und operative Highlights sowie klinische Daten aus der Phase-1-Studie mit DMX-1002 (Ibogain) bekannt

atai Life Sciences gibt Finanzergebnisse des zweiten Quartals 2023 und operative Highlights sowie klinische Daten aus der Phase-1-Studie mit DMX-1002 (Ibogain) bekannt Mehrere Wirkstoffe im...

14 August 2023
GlobeNewswire Inc.

atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)

atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine) Advanced multiple...

10 August 2023
GlobeNewswire Inc.

atai Life Sciences gibt Ergebnisse der Phase-I-Studie zum Übergang von intravenöser zu subkutaner Verabreichung von PCN-101 (R-Ketamin) bekannt

atai Life Sciences gibt Ergebnisse der Phase-I-Studie zum Übergang von intravenöser zu subkutaner Verabreichung von PCN-101 (R-Ketamin) bekannt NEW YORK und BERLIN, Aug. 09, 2023 (GLOBE...

10 August 2023
GlobeNewswire Inc.

atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)

atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine) NEW YORK and BERLIN, Aug. 08, 2023 (GLOBE NEWSWIRE) -- atai Life...

09 August 2023
GlobeNewswire Inc.

atai Life Sciences nimmt an kommenden Investorenkonferenzen im Juni teil

atai Life Sciences nimmt an kommenden Investorenkonferenzen im Juni teil NEW YORK und BERLIN, June 05, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) („atai“), ein im klinischen...

05 June 2023
GlobeNewswire Inc.

atai Life Sciences to Participate in Upcoming June Investor Conferences

atai Life Sciences to Participate in Upcoming June Investor Conferences NEW YORK and BERLIN, June 01, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage...

01 June 2023
GlobeNewswire Inc.

atai Life Sciences legt Finanzergebnisse für das erste Quartal 2023 vor und gibt Highlights und Updates zur Pipeline bekannt

atai Life Sciences legt Finanzergebnisse für das erste Quartal 2023 vor und gibt Highlights und Updates zur Pipeline bekannt RL-007: Erster Patient in der Phase-IIb-Studie zu RL-007 bei...

17 May 2023
GlobeNewswire Inc.

atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates

atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates RL-007: First patient dosed in the Phase 2b study of RL-007 in Cognitive...

11 May 2023
GlobeNewswire Inc.

atai Life Sciences ist Teilnehmer der im Mai stattfindenden Investorenkonferenz

atai Life Sciences ist Teilnehmer der im Mai stattfindenden Investorenkonferenz NEW YORK und BERLIN, May 03, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) („atai“), ein...

04 May 2023
GlobeNewswire Inc.

atai Life Sciences to Participate in Upcoming May Investor Conference

atai Life Sciences to Participate in Upcoming May Investor Conference NEW YORK and BERLIN, May 02, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage...

03 May 2023
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0455-3.051643192491.4911.6481.3560931.41346675DE
40.136510.42780748661.3091.82951.272176611.59344534DE
120.32829.35123042511.11751.8441.0905213501.47031847DE
26-0.043-2.888814242531.48851.8440.93138341.34715165DE
52-0.339-18.99691790421.78452.5290.93135481.55234983DE
156-3.1545-68.57608695654.65.60.9371531.59667055DE
260-9.2545-86.490654205610.7130.9368231.62862734DE

9VC - Frequently Asked Questions (FAQ)

What is the current ATAI Life Sciences NV share price?
The current share price of ATAI Life Sciences NV is 1.4455 €
How many ATAI Life Sciences NV shares are in issue?
ATAI Life Sciences NV has 167,802,396 shares in issue
What is the market cap of ATAI Life Sciences NV?
The market capitalisation of ATAI Life Sciences NV is EUR 242.56M
What is the 1 year trading range for ATAI Life Sciences NV share price?
ATAI Life Sciences NV has traded in the range of 0.93 € to 2.529 € during the past year
What is the PE ratio of ATAI Life Sciences NV?
The price to earnings ratio of ATAI Life Sciences NV is -6.26
What is the cash to sales ratio of ATAI Life Sciences NV?
The cash to sales ratio of ATAI Life Sciences NV is 789.47
What is the reporting currency for ATAI Life Sciences NV?
ATAI Life Sciences NV reports financial results in USD
What is the latest annual turnover for ATAI Life Sciences NV?
The latest annual turnover of ATAI Life Sciences NV is USD 314k
What is the latest annual profit for ATAI Life Sciences NV?
The latest annual profit of ATAI Life Sciences NV is USD -40.22M
What is the registered address of ATAI Life Sciences NV?
The registered address for ATAI Life Sciences NV is WALLSTRABE 16, BERLIN, 10179
What is the ATAI Life Sciences NV website address?
The website address for ATAI Life Sciences NV is www.atai.life
Which industry sector does ATAI Life Sciences NV operate in?
ATAI Life Sciences NV operates in the INTERMEDIATE CARE FACILITIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
E3O1Nexoptic Technology Corp
0.0225 €
(50.00%)
1.48k
D4GDataMetrex AI Ltd
0.0068 €
(30.77%)
60k
VOPInvestigator Resources Ltd
0.0175 €
(29.63%)
1.65k
L7C2Windfall Geotek Inc
0.011 €
(29.41%)
637
K8DWellfield Technologies Inc
0.015 €
(27.12%)
15.45k
47GAGo Metals Corp
0.0134 €
(-46.40%)
333
7N1GT Resources Inc
0.01 €
(-45.95%)
30k
UH7ATennant Minerals NL
0.005 €
(-33.33%)
9.97k
SL5Recharge Resources Ltd
0.0332 €
(-24.20%)
22.48k
8XJAfrican Gold Limited
0.035 €
(-23.91%)
1
D7GNel ASA
0.2028 €
(4.91%)
3.03M
DBKDeutsche Bank AG
18.792 €
(-2.66%)
1.6M
7111BIGG Digital Assets Inc
0.118 €
(2.61%)
1M
3CPXiaomi Corporation
5.109 €
(2.88%)
623.74k
VJFVital Metals Ltd
0.0013 €
(-7.14%)
530k

Discussion

View Full Feed
abracky abracky 3 minutes ago
style="font-size: 16px"Here is What to Know Beyond Why Cleveland-Cliffs Inc. (CLF) is a Trending Stock https://finance.yahoo.com/news/know-beyond-why-cleveland-cliffs-140010688.html
CLF
ttottip ttottip 3 minutes ago
Technological revolution in China!
HOLO
Bull_Dolphin Bull_Dolphin 4 minutes ago
Ex president of Kenya gets it:

https://x.com/libsoftiktok/status/1884641033658433783
RIGATONI RIGATONI 6 minutes ago
Good morning! ~Rig
jimmybob jimmybob 6 minutes ago
UPB in da HIZZLE
jimmybob jimmybob 7 minutes ago
GM FOLKSS
uranium-pinto-beans uranium-pinto-beans 7 minutes ago
$TSLA

🔸 Jefferies maintained a Hold rating on Tesla with a price target of $300

🔸 Baird reduced the price target for Tesla to $440 from $480 but kept the Outperform rating

🔸 Piper Sandler reaffirmed an Overweight rating with a pric
TSLA
ttottip ttottip 7 minutes ago
https://www.reuters.com/technology/artificial-intelligence/alibaba-releases-ai-model-it-claims-surpasses-deepseek-v3-2025-01-29/
HOLO
docterox docterox 8 minutes ago
yeah , big bag over 13mil 0015
DBMM
danieldeubank danieldeubank 9 minutes ago
Jim Sims making the case for domestic REEs

https://www.linkedin.com/posts/cesarconda_pentagon-nationalsecurity-foreignpolicy-activity-7290508326080040960-U9h3?utm_medium=ios_app&utm_source=social_share_sheet&utm_campaign=copy_link
NB
zab zab 9 minutes ago
Fox News is always so nice with a republican administration,  an accident at Washington DC airport,  it will takes months to understand. Fortunately not many were killed. 
uranium-pinto-beans uranium-pinto-beans 11 minutes ago
AAPL, GOOG, GOOGL
Federal judge denies Apple effort to intervene in Google search remedy trial
A U.S. federal judge denied a motion by Apple (AAPL) to intervene as a defendant in the remedy trial of the DOJ vs. Google (GOOGL) case, saying Apple's motion was untimely. Apple made the
AAPL GOOG
uranium-pinto-beans uranium-pinto-beans 11 minutes ago
Meta Platforms price target raised to $750 from $680 at Baird
Baird analyst Colin Sebastian raised the firm's price target on Meta Platforms to $750 from $680 and keeps an Outperform rating on the shares post the Q4 report. The firm says "very upbeat commentary" from Mark Zuckerberg on Meta's
uranium-pinto-beans uranium-pinto-beans 11 minutes ago
Meta Platforms price target raised to $800 from $650 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised the firm's price target on Meta Platforms to $800 from $650 and keeps an Outperform rating on the shares, but acknowledges risk to out-year revenue estimates. Investors must now beli
uranium-pinto-beans uranium-pinto-beans 11 minutes ago
Meta Platforms price target raised to $770 from $700 at Wedbush
Wedbush raised the firm's price target on Meta Platforms to $770 from $700 and keeps an Outperform rating on the shares. The firm notes Meta reported strong Q4 results with revenue 3% ahead of the Street and operating income abou
uranium-pinto-beans uranium-pinto-beans 11 minutes ago
UPS
UPS reports Q4 adjusted EPS $2.75, consensus $2.53
Reports Q4 revenue $25.3B, consensus $25.42B. "I want to thank all UPSers for their hard work and efforts as we closed out 2024 with an outstanding peak, delivering best-in-class service and strong financial results ahead of our
Investor082 Investor082 11 minutes ago
Why gaslight then if you don't believe in it?
NWBO
zab zab 12 minutes ago
Fox News reports,  it's unfortunate,  accidents happen,  that's why pilots train.
cottonmather cottonmather 13 minutes ago
Hey, j-bear. The BOE says the Wilt is about to crash What does that mean? LOL
NCLH
SC8 SC8 14 minutes ago
Gotta keep it real. 4th quarter ended Dec 31, which was also year end. So neither a 4th quarter update or year end update will have anything more than MK's month late Dec downdate did.
RDGL
Doubledown75 Doubledown75 14 minutes ago
His employer is going belly up;)
Gold!!!!
GOLD
TRAPPER JIM TRAPPER JIM 14 minutes ago
LOLOLOLOLOLOL I Hear ya. Not 100% sure what the problem is. It's cranking over really good but not firing at all. 
rolvram rolvram 16 minutes ago
Piper Sandler analyst Alexander Potter has reiterated his $500 price target on $TSLA.
TSLA
marcis marcis 16 minutes ago
I’ve always said waking up with coffe and opening my portfolio to see a zero missing from overnight or the day before is breathtaking at first.

Then you start quickly double checking at different outlets it’s rare but happens.
Especially in startups in OTC

You m
HOMU

Your Recent History

TG
9VC
ATAI Life Sciences NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads